Selector High Conviction Equity Fund

March 2023 Quarterly Newsletter

In this quarterly, we delve further into the role of debt in our lead article, “Understanding debt and why it matters”. We also recommend tuning in to the video referenced in that piece. We discuss company reporting season, highlighting results and matters of interest, and then explore recent events in our article, “Five small steps and one misstep”. We travelled abroad and locally, attending the CSL Europe tour of the company’s manufacturing facilities in Germany and Switzerland, including the recent acquisition of Vifor Pharma. Locally, SEEK and Reliance Worldwide Corporation hosted investors at site briefings, which we comment on in our “Investor Day” articles. We explore the Research and Development (R&D) strategies of several portfolio companies, before commenting on advances in quantum computing. Finally, in our ESG article, we highlight several key points from Iress’ 2022 annual sustainability report.

This update has been prepared by Selector Funds Management Limited (“Selector”) ACN 102 856 347 AFSL 225316 to provide you with general information only. In preparing this update, we do not take into account your investment objectives, financial situation or particular needs. It is not intended to take the place of professional advice and you should not take action in reliance on this information. Neither Selector, or any of its related parties, their employees or directors, provide a warranty of accuracy or reliability for this information or accept any liability to any person who relies on it. Past performance is not an indicator of future performance. Selector does not guarantee the repayment of capital, payment of income or performance. Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.

Unauthorised use, copying, distribution, transmitting, publication, display, or reproduction in whole or in part of the information contained in this material is prohibited without prior written consent from Selector.